Emergency HBOT for Carbon Monoxide Poisoning | Concord, CA

Carbon monoxide (CO) is a colorless, odorless, tasteless gas produced by incomplete combustion of carbon-containing fuels. It is generated by faulty or improperly vented gas appliances (furnaces, water heaters, stoves, fireplaces), generators, vehicles running in enclosed spaces, house fires, and certain industrial exposures. Because it has no perceptible odor, CO can reach dangerous concentrations without warning.

In the United States, carbon monoxide poisoning accounts for more than 50,000 emergency department visits annually and is responsible for approximately 400 to 500 unintentional civilian deaths per year. It is the leading cause of fatal poisoning in America. In the Bay Area and Contra Costa County, CO poisoning incidents occur year-round but increase in winter months when heating appliances are in heavy use and homes are sealed against cold weather. House fires are also a major source of significant CO exposure in our region.

CO poisoning is an approved HBOT indication under the Undersea and Hyperbaric Medical Society (UHMS) guidelines and is one of the most evidence-supported applications of hyperbaric medicine. Treatment criteria that generally indicate HBOT include: loss of consciousness at any point, carboxyhemoglobin levels above 25%, neurological symptoms, cardiac involvement, or pregnancy with any significant CO exposure.

Carbon monoxide binds to hemoglobin with an affinity approximately 240 times greater than oxygen, forming carboxyhemoglobin and rendering hemoglobin incapable of carrying oxygen to tissues. It also binds to myoglobin in muscles and cytochrome c oxidase in mitochondria, directly poisoning the cellular machinery that produces energy. The result is a systemic oxygen crisis at the cellular level even when oxygen is present in the lungs.

The fundamental principle of HBOT treatment for CO poisoning is elegant: by breathing 100% oxygen at 2.5 to 3.0 atmospheres of pressure, the partial pressure of oxygen dissolved in the plasma rises to levels sufficient to fully oxygenate tissues without the use of hemoglobin at all. Simultaneously, the very high oxygen gradient displaces CO from hemoglobin at a massively accelerated rate — reducing the half-life of carboxyhemoglobin from approximately 5 hours (breathing room air) to approximately 23 minutes. This is not a marginal improvement; it is a 13-fold acceleration of CO elimination that directly limits the duration and extent of tissue injury.

HBOT also addresses a less visible but potentially more important mechanism: the prevention of delayed neurological sequelae (DNS). Research has demonstrated that CO exposure triggers a cascade of lipid peroxidation, inflammatory leukocyte adhesion in cerebral vessels, and mitochondrial injury that can produce neurological deterioration days to weeks after the patient appears to have recovered. This delayed injury appears to be mediated by mechanisms distinct from acute CO-hemoglobin binding, and it is the primary target of HBOT's neuroprotective effects. HBOT should be initiated as soon as possible following CO poisoning — ideally within 6 hours of exposure — for maximum benefit.